For some eagerly awaiting a recall, the CDC’s recommendation was all they needed to take action. Gary Valan, a technology consultant in Oakland, Calif., Who said he was over 65, was so eager to receive the callback that he made an appointment Friday afternoon. In an online comment to a New York Times article on booster shots, he wrote, “People in my neighborhood, stay out of my way to the pharmacy. I’ll run over the old ladies to get my shot 🙂 You’ve been warned.
Others were still trying to make sense of the recommendations. Mildred Fine, 96, who lives in an assisted living facility in Baton Rouge, Louisiana, said it had been confusing watching television coverage of the debate on the need for and for whom booster shots.
“They seem to change their minds every day or two,” she said of federal scientists. She looked forward to receiving her Pfizer-BioNTech recall as soon as possible. With so many cases of the virus in Louisiana, she said, she was still hesitant to go to Costco to have her hearing aids fitted or to eat at a restaurant.
State and federal officials said they were not concerned at this time about the vaccine supply, which remains sufficient to cover at least those eligible for booster shots over the course of the years. next months.
“Tens of millions of doses are already being distributed at sites across the country, and pharmacies and states can continue to order additional supplies,” said Sonya Bernstein, senior policy adviser for the Covid-Response Team. 19 of the White House.
But officials are more anxious to get unvaccinated Americans vaccinated, a concurrent campaign that many public health experts say is more important than boosting those already vaccinated. “We can’t let go” with the unvaccinated, said Ms. Hall, the North Dakota councilor, which ranks near the bottom in the United States in terms of immunization rates.
The recall campaign begins amid a heated debate among vaccine experts over what types of benefits additional injections provide and who needs them. Scientists from the Food and Drug Administration and CDC said protection against severe Covid-19 and hospitalization – the metrics they would typically use to assess whether boosters are needed – remained high in all groups of people. ‘age. The FDA’s top vaccine experts have publicly argued that there is no reason to give them to the general population.